BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32920236)

  • 1. Ending the epidemic of HIV/AIDS by 2030: Will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries?
    Assefa Y; Gilks CF
    Int J Infect Dis; 2020 Nov; 100():273-277. PubMed ID: 32920236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ending AIDS by 2030: the importance of an interlinked approach and meaningful youth leadership.
    Gleeson HS; Oliveras Rodriguez CA; Hatane L; Hart D
    J Int AIDS Soc; 2018 Feb; 21 Suppl 1(Suppl Suppl 1):. PubMed ID: 29485749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    Stover J; Glaubius R; Teng Y; Kelly S; Brown T; Hallett TB; Revill P; Bärnighausen T; Phillips AN; Fontaine C; Frescura L; Izazola-Licea JA; Semini I; Godfrey-Faussett P; De Lay PR; Benzaken AS; Ghys PD
    PLoS Med; 2021 Oct; 18(10):e1003831. PubMed ID: 34662333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What will it take to end AIDS in Asia and the Pacific region by 2030?
    Murphy E; Shwe YY; Bhatia R; Bakkali T; Vannakit R
    Sex Health; 2021 Mar; 18(1):41-49. PubMed ID: 33653504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV/AIDS epidemic in Nigeria: progress, problems and prospects.
    Aliyu MH; Varkey P; Salihu HM; Iliyasu Z; Abubakar IS
    Afr J Med Med Sci; 2010 Sep; 39(3):233-9. PubMed ID: 21416794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ending the HIV/AIDS Pandemic
    Eisinger RW; Fauci AS
    Emerg Infect Dis; 2018 Mar; 24(3):413-416. PubMed ID: 29460740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [National HIV/AIDS epidemic estimation and interpretation in China].
    Lyu P; Chen FF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Oct; 40(10):1191-1196. PubMed ID: 31658515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention.
    Godfrey-Faussett P; Frescura L; Abdool Karim Q; Clayton M; Ghys PD;
    PLoS Med; 2022 Sep; 19(9):e1004102. PubMed ID: 36156593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ending the HIV Epidemic: New York's Quest to Become the First State to Reduce HIV Prevalence.
    Morne JE; Tesoriero JM; Martin EG; Birkhead GS; Holtgrave DR; Hagos K; Zucker H
    Public Health Rep; 2020; 135(1_suppl):65S-74S. PubMed ID: 32735198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact and Cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015-2019--Projections with the Spectrum/Goals Model.
    Korenromp EL; Gobet B; Fazito E; Lara J; Bollinger L; Stover J
    PLoS One; 2015; 10(11):e0142908. PubMed ID: 26565696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress and Challenges in Ending HIV and AIDS in Australia.
    Holt M
    AIDS Behav; 2017 Feb; 21(2):331-334. PubMed ID: 28004219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global AIDS Reporting-2001 to 2015: Lessons for Monitoring the Sustainable Development Goals.
    Alfvén T; Erkkola T; Ghys PD; Padayachy J; Warner-Smith M; Rugg D; de Lay P
    AIDS Behav; 2017 Jul; 21(Suppl 1):5-14. PubMed ID: 28124296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2020 5-11 Sep; 396(10252):693-724. PubMed ID: 32334655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human immunodeficiency virus epidemic in India. Current magnitude and future projections.
    Bollinger RC; Tripathy SP; Quinn TC
    Medicine (Baltimore); 1995 Mar; 74(2):97-106. PubMed ID: 7891548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The integration of the global HIV/AIDS response into universal health coverage: desirable, perhaps possible, but far from easy.
    Ooms G; Kruja K
    Global Health; 2019 Jun; 15(1):41. PubMed ID: 31215446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV and AIDS among adolescents who use drugs: opportunities for drug policy reform within the sustainable development agenda.
    Tinasti K
    J Int AIDS Soc; 2018 Feb; 21 Suppl 1(Suppl Suppl 1):. PubMed ID: 29485748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Ending AIDS' between comparison and commensuration and the role of global health indicators.
    Sandset T
    Glob Public Health; 2024 Jan; 19(1):2312435. PubMed ID: 38334114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/AIDS responses in China should focus on the impact of global integration.
    Tang Q; Lu H
    Biosci Trends; 2018; 12(5):507-509. PubMed ID: 30473559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting targets for HIV/AIDS-What lessons can be learned from other disease control programmes?
    Bhatia T; Enoch J; Khan M; Mathewson S; Heymann D; Hayes R; Dar O
    PLoS Med; 2019 Feb; 16(2):e1002735. PubMed ID: 30716068
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.